Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Dyslipidemia Clinical Trials

A listing of Dyslipidemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (18) clinical trials

The Hellenic Postprandial Lipemia Study (HPLS)

The study aims to recruit 1200 patients that are characterized either as high risk or very-high risk for Coronary Heart Disease. It is assumed that an equal number of high risk and very high risk patients will be included in the study. Patients will be invited to participate in the ...

Phase N/A

Assessment of Compliance With European and French Guidelines for the Management of Dyslipidaemias

Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is the foremost cause of premature mortality and of disability-adjusted life years in Europe, and is also increasingly common in developing countries. In the European Union, the economic cost of CVD represents annually 192 billion in ...

Phase N/A

Complications in Hypertension and Obesity

The study in aimed to investigate epidemiology of risk factors in Russian Federation its prognostic value aimed on acceptance of national specific definition of metabolic syndrome and guidelines for its management.

Phase N/A

Dyslipidemia and Diabetic Retinopathy

The purpose of this study is to determine if the reparative cells of blood vessels, called endothelial progenitor cells (EPC's) are defective in people with diabetes. Diabetic retinopathy (DR) is an eye disease related to diabetes. It can cause blurred vision and possible bleeding in the blood vessels in the ...

Phase N/A

Colesevelam Lipids And Sugars South Asian Canadian Trial

This is a prospective, non-controlled, open label, multicenter trial of colesevelam in Canadian South Asian adults at high cardiovascular risk. 15-20 clinical sites from Ontario, Quebec, Manitoba and British Columbia will be selected from CCRN's network of primary care physicians and cardiologists to identify patients having stable type 2 diabetes ...

Phase N/A

Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control

Fimasartan and Rosuvastatin for hypertension and dyslipidemia control

Phase N/A

A Registration Study for Dyslipidemia

This is a registry study to define the status of lipid lowering therapy in Taiwan and the effect of LLT on CVD morbidity and mortality in a large population of patients receiving primary or secondary prevention therapy. The medications will only depend on the decision made by the primary care ...

Phase N/A

Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia

The purpose of this study is to investigate the effectiveness and safety of Olostar Tab in patients with essential hypertension and dyslipidemia

Phase N/A

Genetic Influence on Statin Pharmacokinetics

This study intends to investigate genetic influences on how individuals process statins.

Phase N/A

Circulating Non-coding RNAs and Cardiovascular Outcomes in Patients With Dyslipidemia and Atherosclerosis

Cardiovascular diseases and stroke are the major causes of morbidity and death in Taiwan. Patients with dyslipidemia are prone to atherosclerosis, which predispose to various cardiovascular pathology including coronary artery disease (CAD), ischemic stroke and peripheral artery occlusive disease (PAOD). There are, however, no reliable biomarkers to detect atherosclerotic vascular ...

Phase N/A